Follow
Mario Cazzola
Mario Cazzola
Professor of Hematology, University of Pavia
Verified email at unipv.it
Title
Cited by
Cited by
Year
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
DA Arber, A Orazi, R Hasserjian, J Thiele, MJ Borowitz, MM Le Beau, ...
Blood, The Journal of the American Society of Hematology 127 (20), 2391-2405, 2016
107472016
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics, F Passamonti, AS Buser, SS Teo, R Tiedt, JR Passweg, ...
New England Journal of Medicine 352 (17), 1779-1790, 2005
46352005
Revised international prognostic scoring system for myelodysplastic syndromes
PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F SolÚ, ...
Blood, The Journal of the American Society of Hematology 120 (12), 2454-2465, 2012
33312012
The repertoire of mutational signatures in human cancer
LB Alexandrov, J Kim, NJ Haradhvala, MN Huang, AW Tian Ng, Y Wu, ...
Nature 578 (7793), 94-101, 2020
24312020
Somatic mutations of calreticulin in myeloproliferative neoplasms
KR Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi
New England Journal of Medicine 369 (25), 2379-2390, 2013
23602013
Clinical and biological implications of driver mutations in myelodysplastic syndromes
E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ...
Blood, The Journal of the American Society of Hematology 122 (22), 3616-3627, 2013
19962013
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
New England Journal of Medicine 369 (2), 111-121, 2013
15852013
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
15302020
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
14312011
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ...
Journal of clinical oncology 25 (23), 3503-3510, 2007
12962007
Efficacy and safety of low-dose aspirin in polycythemia vera
R Landolfi, R Marchioli, J Kutti, H Gisslinger, G Tognoni, C Patrono, ...
New England Journal of Medicine 350 (2), 114-124, 2004
12792004
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ...
Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022
11562022
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making
L Malcovati, MGD Porta, C Pascutto, R Invernizzi, M Boni, E Travaglino, ...
Journal of Clinical Oncology 23 (30), 7594-7603, 2005
11242005
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research andá…
F Passamonti, F Cervantes, AM Vannucchi, E Morra, E Rumi, A Pereira, ...
Blood, The Journal of the American Society of Hematology 115 (9), 1703-1708, 2010
10762010
Mutations and prognosis in primary myelofibrosis
AM Vannucchi, TL Lasho, P Guglielmelli, F Biamonte, A Pardanani, ...
Leukemia 27 (9), 1861-1869, 2013
8692013
The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 578 (7793), 122-128, 2020
8642020
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ...
Leukemia 27 (9), 1874-1881, 2013
8142013
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
L Malcovati, E Hellstr÷m-Lindberg, D Bowen, L AdŔs, J Cermak, ...
Blood, The Journal of the American Society of Hematology 122 (17), 2943-2964, 2013
7972013
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
E Rumi, D Pietra, V Ferretti, T Klampfl, AS Harutyunyan, JD Milosevic, ...
Blood, The Journal of the American Society of Hematology 123 (10), 1544-1551, 2014
7512014
Patterns of somatic structural variation in human cancer genomes
Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ...
Nature 578 (7793), 112-121, 2020
7022020
The system can't perform the operation now. Try again later.
Articles 1–20